查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606684

登革熱檢測市場：按類型、組件和最終用戶分類 - 2025-2030 年全球預測

Dengue Testing Market by Type (Dengue IgG/IgM Rapid Test, ELISA-based Test, Real-Time RT-PCR Test), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年登革熱檢測市場價值為4.9978億美元，預計到2024年將達到5.2702億美元，複合年成長率為5.71%，到2030年將達到7.3769億美元。

登革熱檢測市場的特徵是越來越需要準確、及時的診斷，以應對不斷增加的登革熱發病率，主要是在熱帶和亞熱帶地區。包括多種檢測方法，包括核酸增幅檢查（NAAT）、抗體檢測（IgM/IgG）和非結構蛋白1（NS1）抗原檢測，每種方法在靈敏度、特異性和簡便性方面都有獨特的優勢使用。公共衛生活動強調了有效的登革熱檢測的必要性，以減輕疾病的傳播，改善個案管理並指導病媒控制策略。主要應用在臨床實驗室、醫院和公共衛生機構，越來越注重就地檢驗，以確保偏遠地區的快速診斷。影響市場的主要成長要素包括登革熱疫情的增加、政府醫療保健支出的增加、診斷技術的進步以及對病媒控制計劃的日益重視。

主要市場統計
基準年[2023] 4.9978 億美元
預計年份 [2024] 52702萬美元
預測年份 [2030] 73769萬美元
複合年成長率（%） 5.71%

機會在於新興國家診斷基礎設施的擴展，以及針對資源匱乏環境量身定做的快速檢測套組的創新，例如基於側流免疫檢測的檢測試劑盒。然而，他們面臨先進診斷設備成本高、缺乏標準化法規以及一些地區醫療基礎設施不足等挑戰。此外，將登革熱與茲卡和屈公病等類似熱帶疾病區分開來仍然是診斷障礙。專注於可同時檢測多種病原體的多重診斷平台的創新可能為未來的成長鋪平道路。市場的動態本質要求參與者不斷適應和創新，並專注於可負擔性和可及性。與政府機構和非營利組織的合作可以促進分發和接受，特別是在受災地區。總之，在對快速可靠診斷的需求的推動下，登革熱檢測市場提供了成長機會，但需要克服與成本、基礎設施和檢測特異性相關的重大障礙。

市場動態：針對快速發展的登革熱檢測市場揭示的關鍵市場見解

供需的動態交互作用正在改變登革熱檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 登革熱感染增加
    • 政府不斷採取措施提高醫療保健意識
    • 各國醫療保健基礎設施的發展和支出的增加
  • 市場限制因素
    • 診斷試劑套件和測試成本高昂
  • 市場機會
    • 活性化登革熱檢測套件的研發力道
    • 消除蚊媒登革熱的新測試模型的演變
  • 市場挑戰
    • 對現有測試方法的有效性和有效性的擔憂

波特五力：駕馭登革熱檢測市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解登革熱檢測市場的外部影響

外部宏觀環境因素在塑造登革熱檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解登革熱檢測市場的競爭狀況

登革熱測試市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣登革熱偵測市場供應商的績效評估

FPNV 定位矩陣是評估登革熱測試市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製登革熱檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，登革熱檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中登革熱感染發生率增加
      • 擴大政府努力提高醫療保健意識
      • 增加每個國家的醫療基礎設施和支出
    • 抑制因素
      • 診斷試劑套件和測試成本高昂
    • 機會
      • 徹底研發先進的登革熱檢測套件
      • 消除蚊媒登革熱的新測試模型的演變
    • 任務
      • 對現有測試方法的有效性和有效性的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章登革熱檢測市場：按類型

  • 登革熱 IgG/IgM 快速檢測
  • 基於 ELISA 的測試
  • 即時RT-PCR檢測

第7章登革熱檢測市場：依組成部分

  • 器材與設備
  • 實驗室耗材
  • 軟體和資料管理解決方案

第8章登革熱檢測市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 調查機構

第9章 北美和南美登革熱檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區登革熱檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲登革熱檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Abnova Corporation
  • Biogenix Inc. Pvt. Ltd.
  • Biolab Diagnostics{I}Pvt. Ltd.
  • Biopanda Reagents Ltd.
  • Certest Biotec, SL
  • DiaSorin SpA
  • EUROIMMUN Medizinische Labordiagnostika AG
  • F. Hoffmann-La Roche Ltd.
  • Getein Biotech, Inc.
  • InBios International, Inc.
  • Intec Products, Inc.
  • Lexicare Pharma Pvt. Ltd.
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics
  • Reckon Diagnostics Pvt. Ltd.
  • Reliable Pro-detect Biomedicals Pvt. Ltd.
  • Saheb Pharmaceuticals LLP
  • Sri Pharmacare
  • Thermo Fisher Scientific Inc.
Product Code: MRR-69324464D0E5

The Dengue Testing Market was valued at USD 499.78 million in 2023, expected to reach USD 527.02 million in 2024, and is projected to grow at a CAGR of 5.71%, to USD 737.69 million by 2030.

The dengue testing market is characterized by an increasing need for accurate and timely diagnosis to combat the rising incidence of dengue fever, primarily in tropical and subtropical regions. The scope includes various testing methods such as nucleic acid amplification tests (NAATs), antibody-based tests (IgM/IgG), and non-structural protein 1 (NS1) antigen tests, each offering unique advantages in terms of sensitivity, specificity, and ease of use. The necessity for effective dengue testing is underscored by public health drives to mitigate the disease's spread, improve patient management, and guide vector control strategies. Primary applications are found in clinical laboratories, hospitals, and public health agencies, with a growing focus on point-of-care testing to ensure rapid diagnoses in remote areas. Key growth factors influencing the market include rising dengue prevalence, increased governmental healthcare spending, advancements in diagnostic technology, and a stronger emphasis on vector control programs.

KEY MARKET STATISTICS
Base Year [2023] USD 499.78 million
Estimated Year [2024] USD 527.02 million
Forecast Year [2030] USD 737.69 million
CAGR (%) 5.71%

Opportunities arise from expanding diagnostic infrastructure in emerging economies, alongside innovation in rapid test kits tailored for low-resource settings, such as those based on lateral flow immunoassays. However, market growth faces challenges such as the high costs of advanced diagnostic equipment, lack of standardized regulations, and insufficient healthcare infrastructure in some regions. Moreover, differentiating between dengue and similar tropical diseases like Zika and chikungunya remains a diagnostic hurdle. Innovations focusing on multiplex diagnostic platforms that can simultaneously detect multiple pathogens could pave the way for future growth. The market's dynamic nature demands players to continually adapt and innovate, with an emphasis on affordability and accessibility. Collaborations with governmental bodies and non-profit organizations could enhance distribution and acceptance, particularly in the affected regions. In summary, the dengue testing market presents viable opportunities for growth, driven by demand for rapid and reliable diagnosis, yet necessitates overcoming significant barriers related to cost, infrastructure, and test specificity.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dengue Testing Market

The Dengue Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of dengue infections among population
    • Growing government initiatives promoting healthcare awareness
    • Rise in healthcare infrastructure and spendings across economies
  • Market Restraints
    • High costs associated with diagnostic kits and tests
  • Market Opportunities
    • Robust research and development of advanced dengue detection kits
    • Evolution of new testing model to swat mosquito-borne dengue fever
  • Market Challenges
    • Concerns over efficacy and effectiveness of existing testing methods

Porter's Five Forces: A Strategic Tool for Navigating the Dengue Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dengue Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dengue Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dengue Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dengue Testing Market

A detailed market share analysis in the Dengue Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dengue Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dengue Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dengue Testing Market

A strategic analysis of the Dengue Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dengue Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Biogenix Inc. Pvt. Ltd., Biolab Diagnostics {I}Pvt. Ltd., Biopanda Reagents Ltd., Certest Biotec, S.L., DiaSorin S.p.A., EUROIMMUN Medizinische Labordiagnostika AG, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., InBios International, Inc., Intec Products, Inc., Lexicare Pharma Pvt. Ltd., NovaTec Immundiagnostica GmbH, OriGene Technologies, Inc., Quest Diagnostics, Reckon Diagnostics Pvt. Ltd., Reliable Pro-detect Biomedicals Pvt. Ltd., Saheb Pharmaceuticals LLP, Sri Pharmacare, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Dengue Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Dengue IgG/IgM Rapid Test, ELISA-based Test, and Real-Time RT-PCR Test.
  • Based on Component, market is studied across Instruments & Equipments, Laboratory Consumables, and Software & Data Management Solutions.
  • Based on End-User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of dengue infections among population
      • 5.1.1.2. Growing government initiatives promoting healthcare awareness
      • 5.1.1.3. Rise in healthcare infrastructure and spendings across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with diagnostic kits and tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust research and development of advanced dengue detection kits
      • 5.1.3.2. Evolution of new testing model to swat mosquito-borne dengue fever
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over efficacy and effectiveness of existing testing methods
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dengue Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Dengue IgG/IgM Rapid Test
  • 6.3. ELISA-based Test
  • 6.4. Real-Time RT-PCR Test

7. Dengue Testing Market, by Component

  • 7.1. Introduction
  • 7.2. Instruments & Equipments
  • 7.3. Laboratory Consumables
  • 7.4. Software & Data Management Solutions

8. Dengue Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals
  • 8.4. Research Institutes

9. Americas Dengue Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Dengue Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Dengue Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abnova Corporation
  • 3. Biogenix Inc. Pvt. Ltd.
  • 4. Biolab Diagnostics {I}Pvt. Ltd.
  • 5. Biopanda Reagents Ltd.
  • 6. Certest Biotec, S.L.
  • 7. DiaSorin S.p.A.
  • 8. EUROIMMUN Medizinische Labordiagnostika AG
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Getein Biotech, Inc.
  • 11. InBios International, Inc.
  • 12. Intec Products, Inc.
  • 13. Lexicare Pharma Pvt. Ltd.
  • 14. NovaTec Immundiagnostica GmbH
  • 15. OriGene Technologies, Inc.
  • 16. Quest Diagnostics
  • 17. Reckon Diagnostics Pvt. Ltd.
  • 18. Reliable Pro-detect Biomedicals Pvt. Ltd.
  • 19. Saheb Pharmaceuticals LLP
  • 20. Sri Pharmacare
  • 21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. DENGUE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. DENGUE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DENGUE TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DENGUE TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DENGUE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DENGUE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DENGUE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DENGUE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DENGUE TESTING MARKET SIZE, BY DENGUE IGG/IGM RAPID TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DENGUE TESTING MARKET SIZE, BY ELISA-BASED TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DENGUE TESTING MARKET SIZE, BY REAL-TIME RT-PCR TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS & EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DENGUE TESTING MARKET SIZE, BY LABORATORY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DENGUE TESTING MARKET SIZE, BY SOFTWARE & DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DENGUE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DENGUE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DENGUE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2023